Literature DB >> 25766927

Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes.

Douglas D Taylor1, Sahil Shah2.   

Abstract

Viable tumor cells actively release vesicles into the peripheral circulation and other biologic fluids, which exhibit proteins and RNAs characteristic of that cell. Our group demonstrated the presence of these extracellular vesicles of tumor origin within the peripheral circulation of cancer patients and proposed their utility for diagnosing the presence of tumors and monitoring their response to therapy in the 1970s. However, it has only been in the past 10 years that these vesicles have garnered interest based on the recognition that they serve as essential vehicles for intercellular communication, are key determinants of the immunosuppressive microenvironment observed in cancer and provide stability to tumor-derived components that can serve as diagnostic biomarkers. To date, the clinical utility of extracellular vesicles has been hampered by issues with nomenclature and methods of isolation. The term "exosomes" was introduced in 1981 to denote any nanometer-sized vesicles released outside the cell and to differentiate them from intracellular vesicles. Based on this original definition, we use "exosomes" as synonymous with "extracellular vesicles." While our original studies used ultracentrifugation to isolate these vesicles, we immediately became aware of the significant impact of the isolation method on the number, type, content and integrity of the vesicles isolated. In this review, we discuss and compare the most commonly utilized methods for purifying exosomes for post-isolation analyses. The exosomes derived from these approaches have been assessed for quantity and quality of specific RNA populations and specific marker proteins. These results suggest that, while each method purifies exosomal material, there are pros and cons of each and there are critical issues linked with centrifugation-based methods, including co-isolation of non-exosomal materials, damage to the vesicle's membrane structure and non-standardized parameters leading to qualitative and quantitative variability. The down-stream analyses of these resulting varying exosomes can yield misleading results and conclusions.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chromatography; Exosomes; Immunoaffinity; Isolation; Ultracentrifugation

Mesh:

Year:  2015        PMID: 25766927     DOI: 10.1016/j.ymeth.2015.02.019

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  178 in total

Review 1.  Systematic review of factors influencing extracellular vesicle yield from cell cultures.

Authors:  Johann Mar Gudbergsson; Kasper Bendix Johnsen; Martin Najbjerg Skov; Meg Duroux
Journal:  Cytotechnology       Date:  2015-10-03       Impact factor: 2.058

Review 2.  Using exosomes, naturally-equipped nanocarriers, for drug delivery.

Authors:  Elena V Batrakova; Myung Soo Kim
Journal:  J Control Release       Date:  2015-08-01       Impact factor: 9.776

3.  Separating extracellular vesicles and lipoproteins via acoustofluidics.

Authors:  Mengxi Wu; Chuyi Chen; Zeyu Wang; Hunter Bachman; Yingshi Ouyang; Po-Hsun Huang; Yoel Sadovsky; Tony Jun Huang
Journal:  Lab Chip       Date:  2019-03-27       Impact factor: 6.799

Review 4.  Emerging role of extracellular vesicles in the regulation of skeletal muscle adaptation.

Authors:  Ivan J Vechetti
Journal:  J Appl Physiol (1985)       Date:  2019-06-13

5.  Extracellular vesicles isolation and their biomarker potential: are we ready for testing?

Authors:  Theresa L Whiteside
Journal:  Ann Transl Med       Date:  2017-02

6.  Extracellular vesicles: small bricks for tissue repair/regeneration.

Authors:  Simona Taverna; Marzia Pucci; Riccardo Alessandro
Journal:  Ann Transl Med       Date:  2017-02

7.  Balancing yield, purity and practicality: a modified differential ultracentrifugation protocol for efficient isolation of small extracellular vesicles from human serum.

Authors:  Scott M Langevin; Damaris Kuhnell; Melissa A Orr-Asman; Jacek Biesiada; Xiang Zhang; Mario Medvedovic; Hala Elnakat Thomas
Journal:  RNA Biol       Date:  2019-01-13       Impact factor: 4.652

8.  Neuronal Enriched Extracellular Vesicle Proteins as Biomarkers for Traumatic Brain Injury.

Authors:  Hanuma Kumar Karnati; Joseph H Garcia; David Tweedie; Robert E Becker; Dimitrios Kapogiannis; Nigel H Greig
Journal:  J Neurotrauma       Date:  2018-10-25       Impact factor: 5.269

9.  Analysis of circulating non-coding RNAs in a non-invasive and cost-effective manner.

Authors:  Yu-Min Wang; Michael Patrick Trinh; Yongzan Zheng; Kaizhu Guo; Luis A Jimenez; Wenwan Zhong
Journal:  Trends Analyt Chem       Date:  2019-07-05       Impact factor: 12.296

Review 10.  The potential of tumor-derived exosomes for noninvasive cancer monitoring.

Authors:  Theresa L Whiteside
Journal:  Expert Rev Mol Diagn       Date:  2015-08-02       Impact factor: 5.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.